Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert


Search Title by author or title

Clinical outcome of 150 consecutive cases undergoing Descemet's membrane endothelial keratoplasty

Poster Details

First Author: M.Arino SPAIN

Co Author(s):    B. Garcia-Sandoval   I. Jimenez-Alfaro   N. Alejandre              

Abstract Details


To evaluate the clinical outcome of 150 consecutive cases after Descemet membrane endothelial keratoplasty (DMEK) and to assess which parameters may have influenced the clinical outcome


Fundación Jiménez Díaz Universitary Hospital


Consecutive 150 eyes of 138 patients presenting to the Eye Clinic underwent DMEK for Fuchs endothelial corneal dystrophy (FECD), bullous keratopathy and failed corneal transplants. Data including patient demographics, best corrected visual acuity, endothelial cell counts were recorded at baseline, as well as 6 and 12 months after DMEK. Postoperative complications were documented.


At 6 and 12 months postoperatively, 95% of eyes reached a BCVA of ≥20/40 (≥0.5) and 47% ≥20/30 (≥0,8). Compared with preoperative ECD, mean postoperative ECD decreased by 41% and 43% at 6 and 12 months respectively (p<0,05 for all the time points). Eyes with FECD and attached grafts showed better BCVA outcomes and higher ECD (P < 0.05). Within the study period, there was 3 primary failure and no secondary graft failures. The overall rejection rate was 1,3%.


Clinical outcomes supports DMEK as a safe and effective treatment for endothelial failure up to 1 year after surgery, particularly for eyes operated on for FECD and with completely attached grafts.

Financial Disclosure:


Back to Poster listing